Advertisements


Luminex begins clinical trials for Verigene II gastrointestinal assay

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Two $1.5 million grants allow Wake Forest Baptist to join national stroke study

Two five-year grants worth about $1.5 million each will allow Wake Forest Baptist Medical Center to join national clinical trials in the areas of neuroscience and stroke prevention. The first grant places WFBMC among 24 other clinical sites in t.....»»

Category: topSource: bizjournals10 hr. 57 min. ago

Iterum Therapeutics initiates two Phase 3 clinical trials for sulopenem

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall14 hr. 27 min. ago

Curcumin Joins an Elite Group in Clinical Trials for Cancer Prevention

Curcumin Joins an Elite.....»»

Category: topSource: livetradingnews19 hr. 57 min. ago

ETF of the Week: Virtus LifeSci Biotech Clinical Trials ETF (BBC) 

This article was originally published on ETFTrends.com......»»

Category: topSource: foxnewsSep 17th, 2018

Half Of European Clinical Trials Haven’t Reported Results

Half Of European Clinical Trials Haven’t Reported Results.....»»

Category: blogSource: valuewalkSep 12th, 2018

OPKO Health (OPK) Begins RAYALDEE Phase 2 Clinical Trial

OPKO Health's (OPK).....»»

Category: smallbizSource: nytSep 7th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings

The biotech sector notched strong gains last week, capitalizing on the positive overall mark.....»»

Category: earningsSource: benzingaSep 2nd, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings

The biotech .....»»

Category: blogSource: benzingaSep 2nd, 2018

Scholar Rock stock tumbles 11% as Pfizer discontinues similar medication

Scholar Rock Holding Corp. shares dropped 11% in active Thursday trade after Pfizer Inc. announced it plans to stop two ongoing clinical trials for a similar rare-disease drug. The Pfizer drug in question, domagrozumab, w.....»»

Category: topSource: marketwatchAug 30th, 2018

Pfizer, Astellas amend clinical research protocols for two phase 3 trials

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 22nd, 2018

Onconova announces plan for expanding rigosertib clinical trials

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 21st, 2018

Akari Announces First Quarter 2018 Financial Results and Update on its Growing Pipeline of Phase II and Phase III Clinical Trials

Opened three clinical trials in 2018 Trials in which complement dysregulation is the primary disease driver CAPSTONE, the Phase III trial in naïve paroxysmal nocturnal hemoglobinuria (PNH), in which patient treatment has commenced Phase II U.S. trial f.....»»

Category: earningsSource: benzingaAug 17th, 2018

AvroBio to provide update on two clinical trials in second half of year

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 9th, 2018

Gene therapy startup SQZ heads to clinical trials after $72M Series C round

Following the closure of a $72 million Series C funding round on Wednesday, Watertown startup SQZ Biotechnologies plans to launch clinical trials within the next year on a gene therapy. Its CEO contends it could go further and work faster than anythi.....»»

Category: topSource: bizjournalsAug 8th, 2018

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2018 Financial Results

-Obtained Approvals of CTAs in Multiple Countries for CTX001 in β-thalassemia and SCD--Initiation of Clinical Trials for CTX001 in β-thalassemia and SCD on Track for 2018--Preclinical Studies for CTX110 Targeting CD19+ Malignancies Ha.....»»

Category: earningsSource: benzingaAug 7th, 2018

Why Gemphire Is Tuesday’s Big Biotech Loser

Gemphire shares were more than halved on Tuesday after the company provided an update in regards to the clinical hold on gemcabene with respect to clinical trials of longer than six months in........»»

Category: blogSource: 247wallstAug 7th, 2018

Luminex (LMNX) Misses on Earnings in Q2, Margins Contract

Luminex (LMNX) gains on ARIES and VERIGENE platforms in Q2; a solid guidance encourages. Luminex Corporation LMNX reported second-quarter 2018 earnings of 15 cents per share, missing the Zacks Consensus Estimate of 1.....»»

Category: personnelSource: nytAug 7th, 2018

Benzinga"s Daily Biotech Pulse: Biogen, AC Immune Slip Despite Positive Trials, Sarepta Slapped With Clinical Hold

Here's a rou.....»»

Category: earningsSource: benzingaJul 26th, 2018

Benzinga"s Daily Biotech Pulse: Biogen, AC Immune Slip Despite Positive Trials, Sarepta Slapped With Clinical Hold

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling the Peaks (Stocks hitting 52-week highs on July 25) read more.....»»

Category: blogSource: benzingaJul 26th, 2018

Clinical trials database shows termination of Geron"s imetelstat study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 20th, 2018